December Food and Agriculture Regulatory Recap

Get in Touch

Reach out to our team for assistance with your legal and regulatory needs.

Table of Contents

OFW’s Food & Agriculture team regularly monitors announcements and policy issuances from FDA, USDA, and other agencies to keep our clients apprised of regulatory developments that may impact their business. Here are a few of the developments from December that should be highlighted. If you have any questions or would like more information, please do not hesitate to reach out to us.


U.S. Food and Drug Administration (FDA)

  • This month, it was reported that FDA product recalls have seen a significant spike over the past several years.

United States Department of Agriculture (USDA)

  • On December 4, 2023, USDA’s Food Safety and Inspection Service (FSIS) reissued FSIS Directive 7160.3 (Revision 3), “Verification Activities for Advanced Meat Recovery Systems.” The Directive updates and provides instructions to Inspection Program Personnel (IPP) in establishments using advanced meat recovery (AMR) systems, by incorporating instructions from previous, and now cancelled directives.

  • On December 19, 2023, FSIS issued FSIS Directive 8080.1, Revision 8, “Managing Adulterated or Misbranded Meat, Poultry, and Egg Products.” The Directive includes instructions for FSIS inspectors on terminology, agency responsibilities, and public notification procedures for recalls of FSIS-inspected products. The Directive also provides industry guidance for the development of recall plans for meat, poultry, and egg products.

Other  

  • Cosmetics – On December 20, 2023, FDA’s Office of the Chief Scientist (OCS) introduced new proposed guidance documents under development. Over the years, OCS has issued a number of guidance on cosmetics.
    • Registration and Listing of Cosmetic Product Facilities and Products;
    • Insanitary Conditions in the Preparation, Packing, and Holding of Tattoo Inks and the Risk of Microbial Contamination;
    • Mandatory Recalls (to be developed in collaboration with other FDA agencies); and       

    • Records Access (to be developed in collaboration with other FDA agencies)                 

***


Please contact Kyla Kaplan ([email protected]) if you have any questions or are interested in additional assistance.

Disclaimer: The content provided on this blog is intended for general informational and educational purposes only and does not constitute legal advice. The information presented by OFW Law is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship. While we strive to provide accurate and timely information regarding our practice areas, laws and regulations change frequently; therefore, we cannot guarantee that all information is current or applicable to your specific situation. You should not act or refrain from acting on the basis of any content included in this site without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from an attorney licensed in your state. All liability with respect to actions taken or not taken based on the contents of this site is hereby expressly disclaimed.